Cost-utility analysis of latanoprostene bunod eye drops in glaucoma treatment from the perspective of the Brazilian Unified Health System

ABSTRACT Objective: To evaluate the cost-utility of latanoprostene bunod 0.024% as first-line therapy compared to the strategy recommended by the Clinical Protocol and Therapeutic Guidelines for primary open-angle glaucoma of the Brazilian Unified Health System. Methods: A cost-utility analysis wa...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Vanessa Fernandes Ferreira, Ricardo Augusto Paletta Guedes, Alfredo Chaoubah
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Sociedade Brasileira de Oftalmologia 2025-12-01
Schriftenreihe:	Revista Brasileira de Oftalmologia
Schlagworte:	Glaucoma de ângulo aberto Análise de custo-efetividade Sistema Único de Saúde Prostaglandinas Protocolos clínicos Soluções oftálmicas
Online-Zugang:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802025000100233&lng=en&tlng=en
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!